Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report

BMC Neurol. 2021 Oct 26;21(1):408. doi: 10.1186/s12883-021-02448-6.

Abstract

Background: Paraneoplastic neurological syndromes (PNSs) are broad-spectrum disorders that can affect any part of the nervous system varying in core symptoms. Onconeural antibodies, including Hu, Yo, Ri, anti-CV2, amphiphysin, Ma2, and Tr are well-characterized and commonly used for the diagnosis of definite PNS. Generally, anti-CV2 antibodies have usually been associated with cerebellar ataxia, chorea, peripheral and autonomic neuropathies, myelopathy, optic neuritis, and retinitis. However, Parkinsonism has not been reported as the core symptom in patients with anti-CV2 antibodies.

Case presentation: We report a patient with anti-CV2 antibody manifested as Parkinsonism and autonomic dysfunction, which may lead to the diagnosis of multiple system atrophy with predominant Parkinsonism (MSA-P). A lumbar puncture examination was undergone to find a positive anti-CV2 antibody in cerebrospinal fluid. PET-CT showed no tumor. Immunotherapy was adopted and the symptoms were relieved for 5 months. However, with no evidence of tumor, he died after 8 months.

Conclusions: Our findings indicate that PNS with anti-CV2 antibody can be shown as MSA-P mimic. Considering that MSA is a neurodegenerative disease with a poor prognosis, screening for other treatable or controllable factors like PNS presented in this case is necessary when encountering a rapid progressive MSA-mimic patient.

Keywords: Anti-CV2 antibody; Collapsin response mediated protein 5; Dysautonomia; Multiple system atrophy; Paraneoplastic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies
  • Humans
  • Male
  • Multiple System Atrophy* / complications
  • Multiple System Atrophy* / diagnosis
  • Paraneoplastic Syndromes, Nervous System* / diagnosis
  • Parkinsonian Disorders* / diagnosis
  • Positron Emission Tomography Computed Tomography
  • Primary Dysautonomias* / diagnosis

Substances

  • Autoantibodies